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ABSTRACT
Objective: Mental health problems often affect functioning to such an extent that they result
in sick leave. The worldwide reported prevalence of mental health problems in the working
population is 10%–18%. In developed countries, mental health problems are one of the main
grounds for receiving disability benefits. In up to 90% of cases the cause is stress-related, and
health-care utilisation is mainly restricted to primary care. The aim of this study was to assess
the effectiveness of our Minimal Intervention for Stress-related mental disorders with Sick leave
(MISS) in primary care, which is intended to reduce sick leave and prevent chronicity of
symptoms.
Design: Cluster-randomised controlled educational trial.
Setting: Primary health-care practices in the Amsterdam area, The Netherlands.
Participants: A total of 433 patients (MISS n ¼ 227, usual care [UC] n¼ 206) with sick leave
and self-reported elevated level of distress.
Interventions: Forty-six primary care physicians were randomised to either receive training in
the MISS or to provide UC. Eligible patients were screened by mail.
Outcome Measures: The primary outcome measure was duration of sick leave until lasting
full return to work. The secondary outcomes were levels of self-reported distress, depression,
anxiety, and somatisation.
Results: No superior effect of the MISS was found on duration of sick leave (hazard ratio 1.06,
95% confidence interval 0.87–1.29) nor on severity of self-reported symptoms.
Conclusions: We found no evidence that the MISS is more effective than UC in our study
sample of distressed patients. Continuing research should focus on the potential beneficial
effects of the MISS; we need to investigate which elements of the intervention might be useful
and which elements should be adjusted to make the MISS effective.
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INTRODUCTION
Mental health problems often affect functioning to such an
extent that they result in sick leave [1]. The worldwide
reported prevalence in the working population is 10%–18%
[2,3]. These problems cause a public health burden resulting
in enormous personal and ﬁnancial costs [4–7]. Sick leave
often lasts for a long period of time, and in developed
countries, mental health problems are one of the main
grounds for receiving disability beneﬁts [8,9]. In up to 90% of
mental health problems the cause is stress-related [4–6,10]
and health-care utilisation is mainly restricted to primary
care [9].
Common psychopathology, as seen in primary care, often
starts with failure to cope with personal, social, or occupa-
tional demands. The ability to cope or readjust is overtaxed,
and this increases the probability that psychological distress
will follow [11–13]. Sick leave indicates a process of depleting
psychological resources; the patient has stopped trying to
cope, and gives in. When not due to more severe psychiatric
conditions such as depressive disorder or anxiety disorder,
this condition is known as adjustment disorder (Diagnostic
and Statistical Manual of Mental Disorders, fourth edition)
[14,15], neurasthenia (International Classiﬁcation of Diseases,
tenth revision) [16], or nervous breakdown. Because such
patients are labelled with a number of inter-related terms and
deﬁnitions, we use the term stress-related mental disorder
(SMD) to indicate relevant dimensions of psychopathology
that are subacute, but not yet chronic, and clearly related to
stress. Subsequently to SMDs, persistent distress contributes
to more severe psychopathology and chronic conditions such
as depression and anxiety disorders [17].
As yet, there are no evidence-based primary care inter-
ventions to improve functioning and to prevent long-term
sick leave in patients with SMDs. Primary care physicians
(PCPs) are not always aware of the potentially harmful
consequences of sick leave and stress, because the symptoms
seem to be self-limiting. Or, PCPs may be overly cautious and
not question the continuation of sick leave nor ask the
patient to make more effort to cope with the situation,
feeling that this type of response undermines the mutual trust
between patient and doctor [18,19].
METHODS
The present study is a cluster-randomised controlled effec-
tiveness trial in which PCPs were randomised to an
intervention group that was trained to deliver a minimal
intervention for stress-related mental disorders, or to a
control group that delivered care as usual. Distressed patients
on sick leave visiting the practices of both PCP groups were
screened, included, and followed up for one year [20]. The
Medical Ethics Committee of the VU University Medical
Center approved the study protocol and procedures.
Participants
We approached 139 PCPs in two districts where the Depart-
ment of General Practice of the VU University Medical
Center has some type of network positioned. A total of 46
PCPs signed informed consent, both for participating in our
trial and for being randomised to either the intervention
training or to the usual care (UC) group.
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Editorial Commentary
Background: People who take sick leave from work as a result of mental
health problems very often report that the cause is stress-related.
Although stress-related sick leave imposes a significant burden on
individuals and economies, few evidence-based therapies exist to
prevent sick leave in people who are experiencing stress-related mental
health problems. The researchers carrying out this study wanted to
evaluate the effectiveness of an intervention for stress-related mental
health disorders amongst people who had been on sick leave for less
than three months. The intervention involved short training sessions for
primary health-care practitioners, during which the practitioners were
taught how to diagnose stress-related problems; how to provide
information to patients and encourage their recovery and active return
to work; and how to give advice and monitor patients’ recovery. The
researchers carried out a cluster-randomized trial evaluating this training
program, in which 46 primary care practitioners were assigned by chance
to receive either the training program or to practice usual care. Over the
course of the trial, 433 patients with elevated levels of distress and sick
leave were included in the study, 227 of whom were treated by
practitioners receiving the training program and 206 of whom received
usual care. These patients were followed up for 12 months and the
primary outcome studied in the trial was the length of sick leave taken
until full return to work. Secondary outcome measures included patients’
reports of distress, depression, and other symptoms as recorded using
specific questionnaires.
What the trial shows: In the trial, data on the primary outcome measure
was available for 87% of the patients treated by practitioners receiving
the training intervention and 84% of the patients receiving usual care.
When these outcomes were analyzed, there was no evidence of a benefit
of the training program on amount of sick leave taken. Over the course
of the study, the severity of patients’ self-reported symptoms fell in both
groups, but there was no significant difference in symptom severity
between the two groups of patients. A subgroup analysis suggested that
more practitioners in the intervention group recognized patients as
having stress-related mental health problems. Among the group of
patients who were diagnosed as having stress-related mental health
problems, those who were treated by practitioners in the intervention
group seemed to return to work slightly more quickly than those in the
usual care group. However, it is not easy to interpret the findings of this
secondary analysis.
Strengths and limitations: Strengths of this study include the
procedures for cluster randomization, in which primary care practitioners
were randomized, rather than patients. This process ensures that only
patients assigned to the intervention arm receive the benefits of the
intervention, and avoids ‘‘contamination’’ between intervention and
control groups. A further strength includes the blinding of researchers
who were collecting data to the intervention that each practitioner had
received. The findings of the study, however, are difficult to interpret. No
effect of the training intervention was found on the study’s primary
outcome measure; it is possible that the training intervention does
indeed have some benefit, but the benefit may not have been found in
this particular trial because of the inclusion of patients with a very wide
range of problems; in addition the practitioners may have not had the
time or ability to apply what they learnt in the training program.
Contribution to the evidence: Very little evidence exists regarding the
effects of training interventions for improving care of patients with
stress-related mental health problems. The findings of this trial support
those of another study carried out in a primary care setting, which found
that training interventions do not seem to reduce length of sick leave.
However, another study carried out in an occupational health-care
setting, in which patients included in the trial had been recognised as
having stress-related mental disorders, did find some benefit of an
intervention program.
The Editorial Commentary is written by PLoS staff, based on the reports of the
academic editors and peer reviewers.
In order to recruit enough eligible patients, we made use of
the computerised patient record system and approached the
source population of patients (n ¼ 22,740, see Figure 1) by
mail. The source population consisted of all primary care
attenders (20–60 y) who visited consulting hours of the
participating PCPs. PCPs excluded only patients with very
severe psychiatric disorders (mania or psychosis), patients
with terminal illness, or patients with an inadequate
command of the Dutch language. The source population of
attenders was asked to respond only if they met our criteria.
Patient inclusion criteria were symptoms of SMD, and sick
leave for no longer than three months from a paid job.
Symptoms of SMD were measured by means of self-reported
levels of distress (e.g., worrying, listlessness, feeling tense—see
Figure 2) in order to recruit patients. We approached the
source population every one or two weeks, until a sufﬁcient
number of patients from a particular PCP were enrolled.
Final recruitment took place by phone survey. All patients
who had returned the questionnaire and screened positive on
distress and sick leave were contacted. Next, the inclusion
criteria on distress and sick leave for no longer than three
months were checked again. Since there are no diagnostic
criteria, we did not attempt to make a diagnosis of SMD. If
positive, patients were asked for their informed consent to be
included in the study and to have their data collected and
analysed. If the patient consented, the telephonic baseline
interview was started. This method of recruitment, unaffected
by the PCPs’ diagnostic or therapeutic behaviour, ensured
that the recruited patients included in the intervention and
control groups were comparable, and at least not subjected to
selection bias.
Interventions
Over a period of 6–10 wk, the PCPs randomised into the
intervention group received training in the Minimal Inter-
vention for Stress-related mental disorders with Sick leave
(MISS). The training comprised two sessions of 3.5 h and two
regular follow-up sessions of 2 h (total 11 h). The tutors
during the training were the PCP who developed the
intervention (BT) and an occupational physician. During
the training, the PCPs were instructed to use speciﬁc methods
of communication to help the patient, within three con-
sultations on a time-contingent course, to achieve functional
recovery. The MISS takes into account the time constraints
under which a PCP works, as well as the position of a PCP as a
generalist who does not have the capacity to apply highly
specialised interventions. The necessary set of skills was
clearly deﬁned and taught to the PCPs. First, the PCPs were
taught to diagnose an SMD, and to detect symptoms of
depression and anxiety. They were then taught how to give
information and promote the patient’s understanding and how
to emphasise the importance of the patient’s active role with
regard to successful return to work. Subsequently, they
practised giving advice on the content of functional rehabil-
itation. Furthermore, the PCPs were taught active monitoring
to evaluate whether the patient had made efforts to translate
the (work) situation into a problem that could be solved.
Lastly, the PCPs were instructed to consider referral to more
specialised care in case no progress had been made, since the
patient was not likely to beneﬁt from more time off work. The
PCPs in the UC group received no information or advice
about the content of the intervention beforehand, but were
offered the training at the end of the trial. Guidelines for
PCPs are available for the treatment of depression [21] and
anxiety [22], but not yet speciﬁcally for SMDs.
Actual treatment of the participating patients was left to
the discretion of the PCPs, who were informed of a patient’s
participation only after a month. At baseline, patients were
asked whether or not they had planned another visit to their
PCP. If not, they were asked if they were considering another
visit. The PCP was not obliged to apply the MISS or any other
intervention, nor were the patients obliged to visit their PCP.
Objectives
The aim of this study was to assess the effectiveness of our
MISS in primary care, which is intended to reduce sick leave
and prevent chronicity of SMD symptoms in patients. We
hypothesised that the MISS would be more effective than UC,
particularly in patients who had been diagnosed with SMD by
the PCP.
Outcomes
The primary outcome was duration of sick leave in calendar
days from the ﬁrst day of sick leave until full (not part-time)
return to work, lasting for a period of at least 4 wk without
partial or full relapse into sick leave. Patients were asked to
record their days of sick leave, and this information was
collected at baseline and after 2, 6, and 12 mo during
telephone interviews. The secondary outcome measures were
self-reported symptoms of distress, depression, anxiety, and
somatisation. These were measured with the Four-Dimen-
sional Symptom Questionnaire (4DSQ [23]) at baseline and at
2, 6, and 12 mo by mailed questionnaires. Elevated depres-
sion, anxiety, and somatisation scores are indicative of the
existence of a depressive, anxiety, or somatisation disorder,
whereas, in the absence of elevated depression, anxiety, and
somatisation scores, an elevated distress score is indicative of
an SMD. Two months after the baseline assessment, the PCPs
in both groups were asked to ﬁll in a structured questionnaire
on the care provided and any diagnoses or working
hypotheses in the past 3 mo according to their electronic
medical record. All outcomes were measured at individual
level.
Sample Size
To estimate the required sample size, we used a method that
takes into account potential clustering of effects within
practices, the expected difference in outcome between
intervention groups and the required power of the study.
Sample size calculation was done with nQuery Advisor
(Statistical Solutions, http://www.statsol.ie/html/nquery/
nquery_home.html). A related study completed in occupa-
tional health care showed a difference of 15% in full return
to work after a period of three months [24], which we
considered to be a relevant difference for our trial. Expecting
a proportion still on sick leave after 3 mo of 21% in the MISS
group and 36% in the UC group, the sample size needed in
each group was 126 (with a power of 80% at a 0.05 level two-
sided log-rank test for equality of survival curves). Taking into
account an intracluster correlation coefﬁcient of 0.025
because of randomisation at physicians’ level and seven
patients per cluster, a total of 290 patients was needed.
Assuming a dropout rate of 30% (approximately 10% at each
moment of follow-up), enrolment of 415 patients was needed.
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Figure 1. CONSORT Flowchart
doi:10.1371/journal.pctr.0020026.g001
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Randomisation and Blinding
The PCPs were randomly allocated at four different recruit-
ment moments, with block sizes of n¼10, n¼7, n¼14, and n¼
15. A standard procedure was followed to conceal allocation:
the names of the PCPs (and dummy in an uneven group) were
put on a list in random order. Independently, a randomly
ordered list of codes (1¼MISS, 2¼UC) was generated. These
lists were brought together and the ﬁrst PCP on the list was
allocated to the group indicated by the ﬁrst code, and so on.
As a result, 24 PCPs were allocated to the MISS group and 22
to the UC group. After the PCPs were assigned and the MISS
group had received 7 h of training, the patients were enrolled
by screening the source population. Patient selection was
performed by the research team, in order to prevent selection
bias due to the MISS training. The PCPs entered the names
and addresses of the source population, and the source
population was given the inclusion criteria through a
screening questionnaire. The research assistance team con-
tacted the patients who returned the questionnaire by phone,
gave information about the study, and was responsible for the
ﬁnal recruitment. The internal research team, responsible for
the process of data collection, knew the study involved was a
randomised controlled trial, but they had no information on
which PCP was allocated to what condition. Patients and
external interviewers were blinded. They were kept unaware
that two different groups were formed, and were told that the
study was about stress and sick leave.
Statistical Methods
To evaluate the effectiveness of the MISS compared to UC, we
used Cox regression analysis in STATA 8.0 (Stata, http://www.
stata.com/stata8/) with robust standard errors [25] on our
primary outcome measure. Differences in duration of sick
leave were expressed as hazard ratios (HRs) and correspond-
ing conﬁdence intervals (95% conﬁdence interval [CI]) for
the MISS group, compared to the UC group. Estimates of the
intervention effects on our secondary outcome measure were
obtained from linear mixed models in SPSS 12.0 (SPSS, http://
www.spss.com).
All analyses were conducted according to the intention-to-
treat principle and corrected for the clustered design. The
analyses were performed in several stages. First, baseline
similarity of the two groups was examined for all potential
confounders (age, gender, marital status, level of education)
and baseline values of symptom scores (distress, depression,
anxiety, and somatisation). Secondly, the unadjusted associ-
ation between the groups (MISS versus UC) and both
outcome measures were calculated. This association was then
adjusted for each of the potential confounders separately. A
forward selection procedure was followed to include the
potential confounders. For our primary outcome measure
this was done in order of highest change in the regression
coefﬁcient. Only those factors that changed the regression
coefﬁcient by more than 10% were considered to be
confounders, and retained in the model. For our secondary
outcome measure this was done by checking the signiﬁcance
of the p-values. Confounders were retained if they signiﬁ-
cantly contributed to the model (p , 0.05).
Furthermore, we were interested in potential modiﬁcation
of the treatment effects by the PCPs’ diagnosis of SMD, and
therefore preplanned subgroup analyses on diagnosis in the
Cox regression analysis and linear mixed models effect
evaluation. Baseline measures of self-reported symptoms, as
well as diagnoses from the electronic medical records were
examined, so we were able to check for classiﬁcation of
patients and severity of complaints (inclusion is only by self-
reported level of distress with sick leave). We added product
terms for the possible effect-modiﬁer ‘‘diagnosis’’ (with
categories SMD, other mental health problems, or somatic
health problems) and condition (MISS or UC) to the model
and checked for signiﬁcance of the interaction term (p ,
0.10). If signiﬁcant, we proceeded with subgroup analyses.
Since the diagnostic behaviour of the PCPs in the MISS
group might have been changed as a result of the training, we
were aware of confounding by selection bias. If the MISS
PCPs detected more patients with an SMD than their UC
counterparts, they would possibly detect a signiﬁcantly
higher proportion of patients with relatively mild disorders,
which in itself could explain any differences in the patient
outcomes of the groups. Therefore, we tested again for
confounding of the association between the intervention and
Figure 2. Patient Screener
doi:10.1371/journal.pctr.0020026.g002
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the outcome by baseline values of symptom scores (distress,
depression, anxiety, and somatisation).
RESULTS
Participant Flow, Baseline Data, and Numbers
Analysed
Between September 2003 and October 2004, a screening letter
was sent to the source population of 22,740 patients. The
overall response percentage on our screening method was
51.5%; this was measured in a group of 336 randomly selected
attenders. A total of 433 patients (1.9% of 22,470) were
included in the study, 66.3% of whom were women. Table 1
shows that baseline demographics and clinical characteristics
of patients were largely similar, and only a small difference in
level of education was found. The mean number of visits to the
PCP, counted from the day of sick leave up to 3 mo, was 2.55
(standard deviation [SD] 2.12) in the MISS group, and 2.50 (SD
2.23) in the UC group (p ¼ 0.839). With regard to clinical
characteristics, baseline measures of self-reported symptoms
were taken into account. Up to 80% of the patients scored
above threshold on self-reported symptoms of distress, almost
half scored above threshold on symptoms of depression, and
about one-third scored above threshold on symptoms of
anxiety. Symptoms of somatisation also were above threshold
in more than half of the patients.
The participant ﬂow from baseline up to 12 mo follow-up is
represented in a diagram (Figure 1). For our primary
outcome measure—duration of sick leave—data on 197 of
the 227 (87%) of the patients from the MISS group and 174 of
206 (84%) of the patients from the UC group were available.
During follow-up, 44 (19.4%) of the patients in the MISS
group and 47 (22.8%) of the patients in the UC group
withdrew from the study (see Figure 1). Only small differences
were found with regard to baseline demographics and the
clinical characteristics measured with the 4DSQ scores
between the drop-outs and completers.
Outcomes and Estimation
All analyses were adjusted for the clustering effect of PCPs.
Tables 2 and 3 present the scores for primary and secondary
outcome measures. Analysis showed no superior overall effect
of the MISS on our primary outcome measure, days of sick
leave (unadjusted HR 1.06, 95% CI 0.87–1.29; see Table 3).
The median number of sick leave days before return to work
was 96 (95% CI, 81–111) in the MISS group and 102 (95% CI,
75–182) in the UC group. Multilevel analyses showed that the
analyses on our secondary outcome measure needed to be
adjusted for the correlation of repeated measures within
patients. Over 12 mo follow-up, the severity of all symptoms
was reduced signiﬁcantly in both groups (p , 0.001), and on
our secondary outcome measure no signiﬁcant differences
were found between the MISS group and the UC group. A
considerable number of patients still scored above threshold
on self-reported symptoms after 12 mo follow-up. As can be
seen in Table 3, this accounts for around 40% of the patients
on symptoms of distress, and about one-quarter of the
patients on symptoms of depression.
Ancillary Analyses
The baseline diagnoses from the medical records are shown in
Table 4, divided into three categories: SMDs, other mental
health problems, and somatic problems. As can be seen in
Table 4, more PCPs in the MISS group recognised patients as
.......................................................................................................................................................................................
Table 1. Characteristics of Patients with SMD Symptoms and Less Than Three Months Sick Leave
Baseline Measure Category Scores MISS UC
Patients’ characteristics Total, n 277 206
Women, n (%) 153 (67) 134 (65)
Mean age, y (SD) 41.97 (8.8) 39.50 (9.6)
Married or cohabiting, n (%) 174 (77) 148 (72)
Level of education, n (%) Low 59 (27) 46 (22)
Intermediate 94 (42) 102 (50)
High 70 (31) 57 (28)
Mean (SD) number of visits to the PCP,
counted from the day of sick leave þ 3 mo
2.55 (2.12) 2.50 (2.23)
4DSQ scores availablea Total, n (%) 180 (80%) 161 (78%)
Distress, n above threshold (%) 140 (78.2) 131 (81.9)
Depression, n above threshold (%) 86 (48.0) 72 (45.0)
Anxiety, n above threshold (%) 54 (30.2) 48 (30.0)
Somatisation, n above threshold (%) 103 (57.5) 86 (53.7)
aSee Table 3 for mean scores, score ranges, and elevated level scores.
doi:10.1371/journal.pctr.0020026.t001..
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Table 2. Median Number of Days of Sick Leave Before Lasting Full Return to Work
MISS, Number of Days (95% CI)a UC, Number of Days (95% CI)b Hazard Ratio (95% CI) p-Value
96 (81–111) 102 (75–182) 1.06 (0.87–1.29) 0.562
Since the duration of sick leave does not have a normal distribution, we report the median number of days.
an¼ 197
bn¼ 174
doi:10.1371/journal.pctr.0020026.t002..
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having SMD (p ¼ 0.068). These diagnosis categories showed
interaction with the intervention in the Cox regression
analysis on differences in duration of sick leave (p ¼ 0.033).
The PCPs’ diagnosis of both SMDs and other mental health
problems was associated with a longer median duration of sick
leave, compared to the diagnosis of somatic health problems.
Table 5 shows the subgroup analyses, and among patients
diagnosed with SMDs, time to return to work was shorter in
the MISS group than in the UC group (unadjusted HR 1.49
[0.98–2.26], and adjusted HR 1.72 [1.18–2.51]). The HRs for
return to work in the subgroups other mental health problems
and somatic problems slightly favoured the UC group.
However, these differences were small and not statistically
signiﬁcant. For our secondary outcome measure, severity of
symptoms, the interaction of intervention with diagnosis
showed no signiﬁcant results, so no subgroup analyses were
performed. Although the subgroup analyses were planned out
before the trial took place, in no case can this result be
regarded as evidence for a difference between the MISS group
and UC group.
DISCUSSION
Interpretation
We were unable to prove our hypothesis that the MISS would
be more effective than UC, either on our primary outcome
measure nor on the secondary. The median number of days
.......................................................................................................................................................................................
Table 3. Symptom Scores at Follow-Up
4DSQ Scores Time Point MISS UC ICC (p-Value) F (p-Value)
Distress (score range: 0–32;
elevated level: score .10)
Baseline, mean (SD) 19.21 (8.5) 18.79 (8.1) 0.028 (0.107) 1.213 (0.304a)
2-mo follow-up, mean (SD) 14.26 (9.37) 15.24 (8.84)
6-mo follow-up, mean (SD) 11.73 (9.08) 13.16 (9.06)
1-y follow-up, mean (SD) 10.81 (8.91) 10.49 (8.64)
Above threshold after 1-y follow-up, n (%) 75 (44.9%) 55 (39.6%)
Depression (score range: 0–12;
elevated level: score .2)
Baseline, mean (SD) 3.46 (3.7) 3.38 (3.6) 0.015 (0.206) 0.332 (0.802a)
2-mo follow-up, mean (SD) 2.54 (3.53) 2.59 (3.50)
6-mo follow-up, mean (SD) 2.11 (3.31) 2.20 (3.25)
1-y follow-up, mean (SD) 1.74 (2.92) 1.89 (3.04)
Above threshold after 1-y follow-up, n (%) 40 (24.0%) 40 (28.8%)
Anxiety (score range: 0–24;
elevated level: score .7)
Baseline, mean (SD) 5.51 (5.5) 5.41 (5.5) 0.021 (0.219) 0.8990 (0.441a)
2-mo follow-up, mean (SD) 4.19 (5.32) 4.74 (5.61)
6-mo follow-up, mean (SD) 3,12 (4.63) 4.03 (5.20)
1-y follow-up, mean (SD) 2.83 (4.55) 3.14 (4.54)
Above threshold after 1-y follow-up, n (%) 23 (13.8%) 18 (12.9%)
Somatisation (score range: 0–32;
elevated level: score .10)
Baseline, mean (SD) 12.88 (6.9) 12.35 (6.8) 0.048 (0.054) 1.295 (0.275b)
2-mo follow-up, mean (SD) 11.22 (8.01) 10.96 (7.26)
6-mo follow-up, mean (SD) 9.76 (7.48) 10.33 (6.87)
1-y follow-up, mean (SD) 8.34 (6.67) 9.00 (6.96)
Above threshold after 1-y follow-up, n (%) 51 (30.5%) 46 (33.6%)
MISS baseline n¼180 (80%), 2-mo follow-up n¼174 (76.7%), 6-mo follow-up n¼164 (72.2%), 1-y follow-up n¼167 (73.6%). UC baseline n¼161 (78%), 2-mo follow-up n¼142 (68.9%),
6-mo follow-up n ¼ 146 (70.9%), 1-y follow-up n¼ 139 (67.5%).
aAdjusted for age.
bAdjusted for age and level of education.
ICC, intracluster correlation coefficient
doi:10.1371/journal.pctr.0020026.t003..
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Table 4. Diagnosis by Primary Care Physician at Baseline
Diagnosisa Subcategory MISS UC
SMD, n (%) 90 (45) 66 (39)
Other mental health problems, n (% within category) 67 (33) 49 (29)
Depression 24 (36) 17 (35)
Anxiety states; panic disorder 5 (7) 1 (2)
Threshold psychiatric disorders 7 (10) 5 (10)
Nonspecific distress 9 (13) 12 (24)
Somatoform problems 8 (12) 3 (6)
Social and/or private problems 15 (22) 12 (24)
Somatic problems, n (% within category) 44 (22) 56 (33)
Pain in back, neck, or upper extremities 28 (64) 32 (57)
Gastrointestinal, respiratory, cardiovascular,
digestive, or dermatological problems
16 (36) 24 (43)
aChi-squared, p¼ 0.068.
doi:10.1371/journal.pctr.0020026.t004..
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on sick leave before return to work was substantial in both
groups and a considerable number of patients still scored
above threshold on the self-reported symptoms. However, the
severity of symptoms was reduced signiﬁcantly during the 1 y
follow-up.
The MISS did not show an overall effect in our study
sample of patients with symptoms of distress on sick leave.
Possible explanations for the failure to ﬁnd an effect can be
sought within the patients, the PCPs, and the intervention
used. First of all, we shall discuss the patients. There might
have been a problem with the inclusion criteria used. It is
possible that we misclassiﬁed a substantial part of the patients
because our criteria might have been much too broad at both
sides of the severity continuum. As can be seen with the self-
reported symptoms of depression, 24.0% in the MISS group
and 28.8% in the UC group still scored above threshold level
after one year. This substantial group of patients may have
had conditions that were of a more chronic nature (e.g.,
depressive disorder) and needed more extensive care. The
difﬁculty here is that relevant dimensions of psychopathology
that are subacute, but not yet chronic, and clearly related to
stress (e.g., SMD), could not be distinguished in a straightfor-
ward way from more severe psychopathology or from an
admixture of somatic and psychological symptoms. Never-
theless, we used only three questions on distress symptoms
and one question on sick leave to recruit patients who had
visited their PCP. We were convinced of the importance of
undertaking this study, and for that reason might have
underestimated the challenge of diagnosing SMDs. Thus, it is
clear that the evidence base on criteria for the diagnosis of
SMD in patients has to grow substantially.
Furthermore, the lack of effect might be due to the PCPs.
They are the gatekeepers of health care and have extensive
workloads. The MISS takes into account the time constraints
under which a PCP works, as well as the position of a PCP as a
generalist who does not have the capacity to apply highly
specialised interventions. Nevertheless, the PCPs may have
been too busy to carry out any intervention at all.
Alternatively, the intervention might have been too minimal,
or the training hours too short for the PCPs to actually learn
the necessary skills. Unfortunately, except for detection and
labelling of symptoms, the extent to which the PCPs actually
applied their skills was not addressed in this study.
Ancillary analyses showed there was an interaction
between the intervention and detection of SMDs, other
mental health problems, or somatic problems. Both SMDs
and other mental health problems were more frequently
diagnosed by the PCPs in the MISS group than by the PCPs
in the UC group. Since, as a result of the training, the MISS
PCPs were more sensitive to mental disorders and more keen
to diagnose SMDs in particular, it seems logical to expect
that this result would be biased. It seems likely that the SMD
patients in the MISS group were signiﬁcantly less severely
affected than the SMD patients in the UC group. This in turn
could have caused differences in outcome of the SMD
patients in the study group, giving a false (confounded)
impression of the effect of the MISS. However, the SMD
patients in the MISS group actually turned out to have
higher baseline levels of symptoms than the SMD patients in
the UC group (see Table S1). We tested baseline variables for
confounding and as a result controlled for severity of
symptoms, but that did not make the effect of the
intervention in the SMD patients disappear. Nevertheless,
it should be noted that this was an ancillary analysis, and
because of the selection of the SMD patients by the PCPs’
diagnosis, although it was a preplanned subgroup analysis, in
no case can this result be regarded as evidence of a
difference between the MISS group and UC group.
Generalisability
We carried out a randomised controlled trial with only a few
exclusion criteria and thereby allowed considerable variation
due to context, diagnosis, and treatment, so ﬂattering
performances or overestimation of application are unlikely
to be issues. Instead, this considerable variation increases the
relevance of our results because it reﬂects routine clinical
practice instead of ideal circumstances.
Overall Evidence
As far as we know, this is the ﬁrst randomised controlled trial
to evaluate the effects of an intervention in primary care for
SMDs with sick leave as a primary outcome. At the start of our
study, the only comparable study had been performed in
occupational health care by Jac van der Klink et al. [24], who
reported high return-to-work rates after three months (78%
in the intervention group and 63% in the UC group, p¼0.02).
In our study, these rates were lower (51% in the MISS group
and 57% in the UC group, p ¼ 0.239). In the meantime, the
results of one other randomised controlled trial performed in
primary care have been published [1]. In that trial, social
workers were trained to apply the intervention, while PCPs
provided UC for patients in the other group. The study found
no differences between the conditions. Return-to-work rates
after three months were 37% in the intervention group and
40% in the UC group. The more favourable outcomes of this
.......................................................................................................................................................................................
Table 5. Median Number of Days of Sick Leave Before Lasting Full Return to Work, By Subgroups
Subgroups of Diagnosisa MISS, Days, n
(95% CI)
MISS n UC, Days n
(95% CI)
UC n Unadjusted HR
(95% CI)
p-Value,
Unadjusted
Adjusted HR
(95% CI)
p-Value,
Adjusted
Stress-related mental disorder 97 (75–119) 90 170 (143–197) 66 1.49 (0.98–2.26) 0.060 1.72 (1.18–2.51) 0.005b
Other mental health problems 109 (86–132) 67 75 (32–118) 50 0.91 (0.61–1.36) 0.638 0.81 (0.46–1.40) 0.445c
Somatic problems 78 (13–143) 44 21 (8–34) 56 0.73 (0.49–1.07) 0.106 0.76 (0.47–1.12) 0.159d
aChi-squared, p¼ 0.033.
bHR adjusted for baseline values for distress.
cHR adjusted for baseline values for age, level of education and anxiety.
dHR adjusted for baseline values for anxiety.
doi:10.1371/journal.pctr.0020026.t005..
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........................................................................................
study seem to indicate that the occupational setting may be
exceptional, and that the results may not equally apply to
primary care. Moreover, our trial addressed a wider range of
patients than the trial of van der Klink et al., who excluded
patients with major depression or anxiety. The more
beneﬁcial effects of the MISS among patients with a PCP’s
diagnosis of SMD may indicate that these patients more
strongly resemble the participants in the occupational study.
Conclusions
This project represents a further step in the development of
an evidence-based intervention for the treatment of dis-
tressed patients on sick leave. We were unable to show an
effect of the MISS on duration of sick leave. In subgroup
analyses a possible direction for further research was
identiﬁed: namely, whether patients diagnosed with SMDs
may beneﬁt from an effect of the MISS on duration of sick
leave. We feel that emphasis on functional rehabilitation of
the patient is important, because continuation of sick leave
may lead to chronicity and deterioration of symptoms.
Unfortunately, diagnosis of SMD in primary health care
turns out to be less straightforward than we expected, and the
evidence base on criteria for this diagnosis will need to grow
substantially before deﬁnite conclusions can be drawn.
Researchers should take into account the importance of a
diagnostic work-up to differentiate between common mental
health problems, because there is still a lack of generally
accepted criteria to diagnose ‘‘uncomplicated SMD’’ as a level
of psychopathology.
Furthermore, continuing research should focus on the
potential beneﬁcial effects of the MISS; we need to investigate
which elements of the intervention might be useful and which
elements should be adjusted to make the MISS effective.
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Trial Protocol (English)
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